Ati cautat: monitorizare riscuri
Protocol terapeutic: D11AH05 – DCI DUPILUMABUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A16AB03 – DCI AGALSIDASUM ALFA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A09AA02 – DCI PANCREATINUM (concentraţia 35.000 U FE) (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: R07AX30 – DCI LUMACAFTORUM+IVACAFTORUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)
Protocol terapeutic: L04AA25-SHUa – DCI ECULIZUMABUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)
Protocol terapeutic: L04AA25-HPN – DCI ECULIZUMABUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)
Protocol terapeutic: L01XE54 – DCI GILTERITINIB (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)
Protocol terapeutic: L01XE31 – DCI NINTEDANIBUM (OFEV) (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)
Protocol terapeutic: R07AX32 – DCI IVACAFTORUM + TEZACAFTORUM + ELEXACAFTORUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: R03DX05-UCS – URTICARIE CRONICĂ SPONTANĂ – TERAPIE BIOLOGICĂ (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
